Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 05, 2023

BUY
$1.61 - $2.54 $44,275 - $69,850
27,500 New
27,500 $49,000
Q3 2022

Nov 14, 2022

SELL
$0.73 - $3.74 $11,570 - $59,279
-15,850 Reduced 88.8%
2,000 $6,000
Q2 2022

Aug 12, 2022

BUY
$2.2 - $4.2 $7,150 - $13,650
3,250 Added 22.26%
17,850 $42,000
Q1 2022

May 13, 2022

BUY
$2.83 - $8.69 $41,318 - $126,874
14,600 New
14,600 $59,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $9.25B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Almanack Investment Partners, Llc. Portfolio

Follow Almanack Investment Partners, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Almanack Investment Partners, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Almanack Investment Partners, Llc. with notifications on news.